M LC 300 (Lithium carbonate extended release 300 mg)
Pill imprint M LC 300 has been identified as Lithium carbonate extended release 300 mg.
Lithium is used in the treatment of bipolar disorder; mania; schizoaffective disorder; intermittent explosive disorder; cyclothymic disorder (and more), and belongs to the drug class miscellaneous antipsychotic agents. There is positive evidence of human fetal risk during pregnancy. Lithium 300 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for M LC 300 (Lithium carbonate extended release 300 mg)
- Imprint:
-
M
LC 300 - Strength:
- 300 mg
- Color:
- Peach
- Shape:
- Round
- Availability:
- Prescription only
- Drug Class:
- Miscellaneous antipsychotic agents
- Pregnancy Category:
- D - Positive evidence of risk
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Mylan Pharmaceuticals Inc.
More resources
Lithium carbonate extended release is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...
